NACo Opioid Settlement Summit: Opportunities for County, State & Federal Partnership
Virtual Event | On-Demand Recording
The recording from this event is available on-demand. If you have trouble accessing the recording, please email nacomeetings@naco.org.
As of 2023, state and local governments have negotiated over $50 billion in settlements from companies in the pharmaceutical industry. The national opioid settlements reflect years of coordinated legal action and intergovernmental cooperation within and between states. As the settlements are paid out over the next 17 years, continuous intergovernmental coordination is key to achieving the maximum impact of these investments. This event will bring together leaders from all levels of government to discuss effective strategies for investing opioid settlement funds and to explore opportunities to strengthen intergovernmental coordination in our nation’s response to the opioid epidemic.
Stakeholders in the DC area are encouraged to attend this event in-person by registering at the link above.
Event Recording
Use the player on this page, or click the link below to watch in a new window.
Featured Speakers
Miriam E. Delphin-Rittmon, Ph.D.
Dr. Rahul Gupta
Dr. Gregory Wm. Branch
Anthony E. "Tony" McDowell
Dr. Gina Nikkel
Stephen J. Acquario, Esq.
Kevin Leonard
Daniel Hinkle
Dr. Latika Davis-Jones
Agenda
Featured Initiative
Opioid Solutions Center
NACo's Opioid Solutions Center empowers local leaders to invest resources in effective treatment, recovery, prevention and harm reduction practices that save lives and address the underlying causes of substance use disorder.
Counties turn to universities, hard data to gauge opioid settlement impact
Evaluating the efficacy programming is often the hardest and most neglected piece of allocating opioid settlement funds.
County offers leave for EMS volunteers
Facing challenges that could further shrink its pool of EMS volunteers, McLean County, N.D. eased the process for county staff to participate.
DEA announces temporary scheduling of synthetic kratom substances
On July 1, the U.S. Drug Enforcement Administration (DEA) filed two Notices of Intent to temporarily place highly concentrated and synthetic kratom-related substances into Schedule I of the Controlled Substances Act. Additionally, the Office of the Assistant Secretary for Health (OASH) issued a Request for Information seeking public comment on scientific data on the proposed threshold level.
Minnesota county library addresses public health
Dakota County, Minn. identified libraries as trusted accessible spaces to be used as community health hubs.
